查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1855464

球虫药物市场依最终用途、通路、产品类型及剂型划分－2025-2032年全球预测

Anticoccidial Drugs Market by End Use, Distribution Channel, Product Type, Form - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，球虫药物市场规模将达到 37.1 亿美元，复合年增长率为 9.71%。

关键市场统计数据
基准年 2024 17.6亿美元
预计年份：2025年 19.3亿美元
预测年份 2032 37.1亿美元
复合年增长率 (%) 9.71%

简单介绍球虫疗法在现代动物健康管理中的策略重要性

在集约化畜牧系统中，球虫药物对于维持肠道健康和生产效率至关重要。随着畜牧业生产集约化程度的提高，针对性化学预防和治疗性介入的作用日益凸显，以应对降低生产力、动物福利和饲料转换率的疾病压力。在此背景下，对于兽医团队、饲料生产商、监管机构和商业性相关人员而言，了解不断发展的球虫治疗方法至关重要，因为他们需要在疗效、安全性和永续性之间寻求平衡。

本报告整合了近期科学进展、监管措施、不断变化的经销管道以及终端用户动态，全面展现了现代球虫的实践现状。报告探讨了产品配方选择、物种特异性饲养方式的转变以及新出现的抗药性模式如何影响治疗方法的选择和供应链检验。透过建立当前实践和新兴压力的清晰基准，本分析为循证研究投资、市场准入和政策参与提供了支持。

在整个分析过程中，我们将重点放在对决策者的实际影响：配方和交付选择如何与农场工作流程交织，分销模式如何影响可及性和管理，监管和贸易发展如何影响采购和生产策略等等。引言部分讨论了变革性转变、关税影响、细分市场洞察、区域差异、竞争对手行动、可操作的建议、方法论和总体结论，以指南后续章节中的营运和策略应对措施。

畜牧业球虫药物研发、使用模式和管理正在发生变革性转变

近期趋势将科学、监管和市场因素融合在一起，正在改变球虫疗法的研发、分销和应用方式。病原体基因组学和体外药敏试验的进步提高了我们检测和监测抗药性的能力，从而能够开发更有针对性的产品并制定局部治疗策略。同时，动物福利的迫切需求和零售商主导的品质标准正促使生产商重新评估预防方法，转而采用综合疾病管理方法，以减少对含药饲料的使用。

同时，产品格局也在不断演变。离子载体因其高效性和饲料相容性而备受青睐，而合成化合物在治疗抗药性或在特定生命週期阶段需要使用时仍然发挥着重要作用。配方创新，例如改良的预混合料和稳定剂，能够提高给药精度，并更轻鬆地整合到饲料和饮水系统中。分销管道也在改变。直销关係和专科兽医诊所管道正在加强，而数位平台和线上药局则扩大了产品的可及性，并改变了消费者的购买行为。

此外，永续性和监管合规性方面的考虑正在推动供应链重组。製造商和饲料整合商正在投资上游品管、可追溯性和替代采购，以降低贸易中断和监管变化的风险。总而言之，这些变化正在重塑整个球虫生态系统的竞争动态、研究重点和商业实践，这就要求药物研发商、委託製造、饲料公司和动物服务供应商制定相应的适应策略。

分析美国2025年宣布的关税对球虫供应链和采购的累积营运和策略影响

2025年实施的关税措施对整个球虫药物供应链、生产投入和分销环节都产生了连锁反应。对某些活性药物成分和饲料中间体征收的进口关税增加了依赖海外采购的生产商和饲料厂的到岸成本。为此，采购团队正在重新评估其供应商组合，优先考虑替代来源，寻找可节省成本的生产窗口，并加强与契约製造的沟通，以减少利润下滑。

这些由关税主导的调整也加速了近岸外包的考量与投资。拥有灵活生产布局的公司正在重新分配生产或增加库存缓衝，以维持供应的连续性。同时，由于避险能力有限，小型生产者和区域饲料整合商面临更显着的成本压力，促使他们进行整合和建立策略联盟，以共用规模优势。关税带来的监管合规和海关手续的复杂性增加了行政成本，延长了交货时间，并影响了订单排序。

重要的是，分销管道已适应关税带来的成本变化。直销团队和专业经销商加强了与客户基于价值的对话，强调配方优势和能够证明高价合理的管理计划。线上药局和数位化采购平台可帮助一些买家从未受影响的地区采购替代配方和学名药，但品质保证和法规遵循仍然是主要的资讯来源。总体而言，关税的累积影响迫使企业重组筹资策略并增加对营运韧性的投资，从而影响了整个球虫价值链的商业性定位。

整合最终用途、分销管道、产品类型和配方选项等关键细分洞察，有助于制定有针对性的策略倡议。

市场区隔明确了治疗需求与推广障碍的交会点。根据最终用途，市场细分涵盖牛、家禽和猪，其中家禽市场也细分为不同的生产系统：肉鸡和蛋鸡。这些物种和系统层面的差异导致了不同的治疗时机、给药策略以及与饲料管理实践的整合。饲料添加剂配方和浸没式治疗方案与肉鸡的生长週期和蛋鸡的饲养管理方式不尽相同，因此需要分别进行产品开发和市场推广。同一物种内不同治疗层级之间的转换也因生产规模、生物安全通讯协定以及零售商和加工商的具体要求而异。

从分销管道细分来看，市场研究涵盖了直销、线上药局和专卖店三大通路，每种通路都为终端用户提供了不同的购买途径和不同程度的技术支援。直销通常辅以综合管理计画和正式的用药指导，而线上药局虽然扩大了购买管道，但需要强大的数位化资讯支援才能确保正确用药。在独立兽医诊所和饲料合作社高度集中的地区，专卖店发挥关键作用，它们提供的社区咨询服务能够影响产品选择和对推荐通讯协定的遵循。

按产品类型进行细分有助于明确临床应用和抗药性管理策略。离子载体包括拉萨罗、孟宁素和沙利霉素，而合成抗菌药物包括硝基呋喃、奎诺酮和磺胺类药物，突显了它们在作用机制、监管考虑和治疗定位方面的差异。离子载体通常用作特定生产系统中的连续饲料添加剂，而合成抗菌药物则常用于标靶治疗疗程或轮换方案。市场细分考察了饲料添加剂、液体和预混合料三种剂型，每种剂型在剂量精度、农场实施便捷性和与现有饲料厂的整合性方面各有优劣。预混合料支持集约化饲料生产和稳定的剂量控制，饲料添加剂可实现大规模的连续预防，而液体剂型则允许在水性系统中灵活给药，以进行靶向干预。

区域洞察聚焦在美洲、欧洲、中东和非洲以及亚太地区不同的驱动因素及其对产品策略的影响。

区域性因素影响着监管重点、疾病压力和采购行为。在美洲，生产规模、一体化供应链和加工商主导的品质管理系统正在催生对稳定、与饲料相容的球虫的需求。在欧洲、中东和非洲，对某些合成化合物的监管审查以及对抗菌药物管理的重视，正在推动兼顾疗效和残留风险的产品的普及。在许多欧洲市场，零售商的承诺和以动物福利主导的倡议也在影响人们转向综合管理方法，并减少对预防性药物的依赖。

亚太地区生产体系和法规环境的复杂性，对需求和分销模式均有影响。该地区部分地区家禽养殖密度高，对便捷、经济的抗球虫方案的需求强劲；同时，新的监管协调措施也提高了人们对残留监测和品质保证的期望。此外，数位商务和不断发展的兽医服务正在加速亚太部分地区采用替代分销管道。不同地区的抗药性特征、饲料厂密度以及合约养殖模式的普及程度，共同决定了哪些产品类型和形式更受青睐，凸显了製定区域性监管策略和商业性模式的必要性。

对主要企业进行竞争考察，重点关注其策略行动、研发重点领域和合作模式，这些因素共同塑造了球虫领域的竞争动态。

市场参与企业展现出多元化的策略姿态，这反映了他们的规模、产品组合广度和垂直整合程度。大型跨国动物用药品公司优先考虑配方稳定性、抗药性缓解技术以及结合诊断和管理专案的综合服务方面的创新。这些公司投资于全球监管能力建设，以应对不同的残留和註册要求，并通常采用多通路销售模式，以涵盖行业整合者和小型独立生产商。中型和区域性製造商则利用接近性饲料厂网路和合约养殖丛集的优势，专注于具有成本竞争力的配方、本地监管专业知识和供应链可靠性。

在整个价值链中，随着企业寻求在不进行大量资本投资的情况下扩大产能，製造外包和联合开发伙伴关係正变得越来越普遍。药物研发商、学术机构和诊断服务提供者之间的合作研究协议旨在加速开发抗药性监测工具和优化给药方案。同时，饲料添加剂专家和预混合料供应商正透过产品客製化、技术服务和卓越的可追溯性来脱颖而出，以满足一体化生产商的严苛需求。这些企业层面的倡议表明，市场竞争优势正日益不再仅仅来自分子所有权，而是来自配方、监管关係、农场咨询能力等方面的专业知识的整合。

为行业领导者提供切实可行的建议，以使其产品开发、商业策略和管理与不断变化的市场现实保持一致。

行业领导者应优先考虑将产品功效与农场实践和抗药性管理相结合的综合方法。投资诊断和监测伙伴关係将有助于提高治疗性介入的针对性，并支持以数据主导的轮调和合併用药策略，从而维持疗效。同时，提高配方与常用饲料厂工作流程和灌服系统的兼容性，可以减少推广应用的障碍，并提高给药的准确性。这些技术投资应与兽医和饲料管理人员的教育计划相结合，以确保正确使用并强化管理原则。

在商业方面，企业应使其分销策略多元化，包括加强直销能力、与专业供应商合作以及调整数位化管道以扩大覆盖范围并保持品质保证。受贸易相关成本波动影响的企业应评估近岸外包方案、合约避险技巧以及供应商多元化，以维持业务连续性。最后，企业领导者必须积极与监管相关人员和加工商就残留监测、标籤和可接受使用框架进行沟通。综合运用这些措施，可以使商业性目标与维持长期疗效这一必要条件保持一致。

调查方法：详细说明资料收集、检验过程以及为确保研究结果的可靠性和适用性而采用的分析方法。

本研究采用混合方法，结合一手研究、二手文献分析和供应链图谱，建构了全面的依证。一级资讯来源包括对兽医、饲料厂经营者、委託製造和分销专业人员的结构化访谈，以了解实务情况和实施障碍。二级资讯来源包括关于球虫生物学和治疗效果的同行评审文献、监管文件、产品标籤以及提供技术和政策背景的官方贸易文件。

数据采用三角验证法，反覆最后覆核与文件层面的证据进行交叉核对，以检验趋势并调和相互矛盾的解释。在适用情况下，我们查阅了区域监管资料库和海关文件，以了解关税和登记限制的影响。我们的分析方法着重于定性主题综合和区域比较分析，而非定量市场规模评估，从而确保方法论的透明度，同时提供可操作的策略资讯。本研究的局限性包括各国和各地区报告标准的差异以及抗药性监测数据的不断变化，这些局限性在本研究中透过保守的解释和对证据强度的清晰呈现来解决。

结论：概述了从事球虫领域工作的相关人员的战略要务以及实现永续治疗效果的途径。

球虫市场格局正受到科学进步、监管环境、分销模式转变和贸易动态的影响而重塑。维持治疗效果需要整合策略，将产品创新与管理、稳健的供应链设计以及有针对性的商业性合作相结合。成功的公司将是那些能够将製剂研发与农场实践相结合、投资于抗药性监测伙伴关係并采用既能保证品质又能扩大可及性的分销模式的公司。

展望未来，相关人员应将抗药性管理和监管一致性视为核心策略重点，而非将合规视为事后考虑。这样做将保障疗效，支持动物福利和食品安全目标，并为加工商和生产商提供差异化的提案主张。未来几年，对诊断、配方相容性和适应性采购的关注将决定市场竞争格局，并促进球虫在不同生产系统中的永续利用。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 艾美球虫对传统离子载体药物抗药性的增强促进了新型合成球虫药物的研发。
  • 利用精密农业监测工具优化家禽养殖场球虫药物给药方案
  • 扩大针对有机和自由放养养鸡生产商的草药和植物性球虫产品范围
  • 生物技术新兴企业公司与动物保健公司建立策略伙伴关係，以加速开发基于疫苗的抗球虫解决方案
  • 整合肠道微生物组分析以客製化球虫方案并改善畜群健康状况
  • 对抗生素生长促进剂的更严格监管正在加速向疫苗接种和替代性球虫控制方法的转变。
  • 结合离子载体和化学活性剂开发抗多重抗药性球虫药物
  • 利用机器学习预测模型对肉鸡养殖场球虫疫情进行早期检测与标靶治疗

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依最终用途球虫药物市场

  • 牛
  • 家禽
    • 肉鸡
    • 下层鸡
  • 猪

9. 按分销管道分類的球虫药市场

  • 直销
  • 网路药房
  • 专卖店

第十章 依产品类型分類的球虫药市场

  • 离子载体
    • 拉萨罗
    • 孟宁素
    • 沙利霉素
  • 合成药物
    • 硝基呋喃
    • 奎诺酮
    • 磺胺类药物

11. 按剂型分類的球虫药市场

  • 饲料添加剂
  • 液体
  • 预混合料

12. 各地区球虫药市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章球虫药市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各国球虫药市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Zoetis Inc.
    • Merck & Co., Inc.
    • Elanco Animal Health Incorporated
    • Boehringer Ingelheim International GmbH
    • Bayer Aktiengesellschaft
    • Ceva Sante Animale
    • Kemin Industries, Inc.
    • Huvepharma AD
    • Novus International, Inc.
    • DCBL Pharmaceuticals Ltd.
Product Code: MRR-456C7E8666FE

The Anticoccidial Drugs Market is projected to grow by USD 3.71 billion at a CAGR of 9.71% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.76 billion
Estimated Year [2025] USD 1.93 billion
Forecast Year [2032] USD 3.71 billion
CAGR (%) 9.71%

A concise introduction framing the strategic importance of anticoccidial therapies in modern livestock health management

Anticoccidial drugs remain central to maintaining gastrointestinal health and production efficiency across intensively managed livestock systems. As the industry has intensified, the role of targeted chemoprophylaxis and therapeutic interventions has expanded to address disease pressure that would otherwise undermine productivity, animal welfare, and feed conversion outcomes. In this context, understanding the evolving landscape of anticoccidial approaches is essential for veterinary teams, feed manufacturers, regulatory bodies, and commercial stakeholders seeking to balance efficacy, safety, and sustainability.

This report synthesizes recent scientific advances, regulatory movements, distribution channel evolution, and end-use dynamics to provide an integrated view of contemporary anticoccidial practice. It examines how product formulation choices, shifts in species-specific husbandry, and emerging resistance patterns are influencing treatment selection and supply chain decisions. By establishing a clear baseline of current practice and emerging pressures, the analysis supports evidence-based planning for research investment, market entry, and policy engagement.

Throughout the analysis, emphasis is placed on pragmatic implications for decision-makers: how formulation and delivery choices intersect with on-farm workflows, how distribution models affect accessibility and stewardship, and how regulatory and trade developments influence sourcing and manufacturing strategies. The introduction thus frames the subsequent sections that explore transformative shifts, tariff impacts, segmentation insights, regional nuances, competitor behavior, actionable recommendations, methodology, and the overarching conclusions that guide operational and strategic responses.

Transformative shifts reshaping anticoccidial drug development, use patterns, and stewardship across animal agriculture

Recent years have seen a convergence of scientific, regulatory, and market drivers that are transforming how anticoccidial therapies are developed, distributed, and deployed. Advances in pathogen genomics and in vitro susceptibility testing have improved the capacity to detect and monitor resistance, enabling more targeted product development and localized treatment strategies. At the same time, animal welfare imperatives and retailer-driven quality standards are pushing producers to reassess prophylactic approaches and favor integrated disease management practices that reduce blanket medicated feed usage.

Concurrently, the product landscape is evolving. Ionophores continue to be valued for their efficacy and feed-additive compatibility, while synthetic compounds remain critical in therapeutic contexts where resistance or specific lifecycle stages necessitate their use. Formulation innovation-such as improved premixes and stabilized liquids-has increased dosing precision and ease of integration into feed and water systems. Distribution channels are also shifting; direct sales relationships and specialty veterinary channels are strengthening, while digital platforms and online pharmacies expand accessibility and alter purchasing behavior.

Moreover, sustainability and regulatory compliance considerations are driving supply chain reconfiguration. Manufacturers and feed integrators are investing in upstream quality control, traceability, and alternative sourcing to mitigate exposure to trade disruptions and regulatory changes. Taken together, these shifts are recalibrating competitive dynamics, research priorities, and operational practices across the anticoccidial ecosystem, demanding adaptive strategies from pharmaceutical developers, contract manufacturers, feed companies, and veterinary service providers.

Analyzing the cumulative operational and strategic consequences of United States tariffs announced in 2025 on anticoccidial supply chains and procurement

The tariff measures introduced in 2025 have had ripple effects across the supply chains that support anticoccidial drug availability, manufacturing inputs, and distribution economics. Import duties on certain active pharmaceutical ingredients and intermediary feed materials have increased landed costs for manufacturers and feed mills that rely on international sourcing. In response, procurement teams have re-evaluated supplier portfolios, prioritized alternative origins, and escalated conversations with contract manufacturers to identify cost-saving production windows and mitigate margin erosion.

These tariff-driven adjustments have also accelerated nearshoring conversations and investments. Companies with flexible manufacturing footprints have reallocated production or increased inventory buffers to preserve supply continuity. Simultaneously, smaller producers and regional feed integrators have faced more pronounced cost pressures due to limited hedging capabilities, prompting consolidation and strategic partnerships to share scale advantages. Regulatory compliance and customs complexity introduced by tariffs have added administrative overhead, increasing time-to-delivery and influencing ordering cadence.

Importantly, distribution channels have adapted to tariff-induced cost volatility. Direct-sales teams and specialty distributors have intensified value-based conversations with customers, emphasizing formulation benefits and stewardship programs that justify premium pricing. Online pharmacies and digital procurement platforms have helped some buyers source alternative formulations or generics from non-impacted jurisdictions, though quality assurance and regulatory conformity remain primary considerations. Overall, the cumulative impact of tariffs has reshaped sourcing strategies, compelled operational resilience investments, and influenced commercial positioning across the anticoccidial value chain.

Key segmentation insights synthesizing end use, distribution channels, product types, and formulation choices to inform targeted strategic initiatives

Segmenting the market clarifies where therapeutic demand and adoption barriers intersect. Based on end use, the market is studied across cattle, poultry, and swine, with poultry further examined through the distinct production systems of broiler chicken and layer chicken; these species- and system-level differences drive divergent treatment timing, dosing strategies, and integration with feed management practices. Feed additive formulations and in-water therapeutics align differently with broiler cycles versus layer management, creating separate product development and marketing imperatives. Transitioning between therapeutic classes within a species depends on production scale, biosecurity protocols, and retailer or processor specifications.

Considering distribution channel segmentation, the market is studied across direct sales, online pharmacies, and specialty stores, each offering distinct pathways to end users and varying degrees of technical support. Direct sales relationships often support integrated stewardship programs and formalized dosing guidance, while online pharmacies expand access but require robust digital information to preserve correct usage. Specialty stores play a key role in regions with dense independent veterinary practices and feed cooperatives, providing localized advisory services that influence product choice and adherence to recommended protocols.

Product type segmentation clarifies clinical application and resistance management strategies. The market is studied across ionophores and synthetic drugs, with ionophores further studied across lasalocid, monensin, and salinomycin, while synthetic drugs are further studied across nitrofurans, quinolones, and sulfonamides; this taxonomy highlights differing mechanisms of action, regulatory considerations, and therapeutic niches. Ionophores are commonly employed as continuous feed additives in certain production systems, whereas synthetics are more often used for targeted therapeutic courses or in rotation programs. Form-based segmentation reveals how delivery impacts adoption: the market is studied across feed additive, liquid, and premix forms, each providing trade-offs in dosing accuracy, ease of on-farm implementation, and integration with existing feed mill operations. Premix formats support centralized feed production and consistent dosing, feed additives enable continuous prophylaxis at scale, and liquids offer flexible administration in water systems for targeted interventions.

Regional insights highlighting heterogenous drivers across the Americas, Europe, Middle East & Africa, and Asia-Pacific and their implications for product strategy

Regional dynamics shape regulatory priorities, disease pressures, and procurement behavior. In the Americas, production scale, integrated supply chains, and processor-led quality programs create demand for consistent, feed-compatible anticoccidial solutions; producers often favor products that align with high-throughput systems and stringent food-safety requirements. Across Europe, Middle East & Africa, regulatory scrutiny on certain synthetic compounds and strong emphasis on antimicrobial stewardship steer product adoption toward options that balance efficacy and residue risk. Retailer commitments and welfare-driven initiatives in many European markets also influence the transition toward integrated management approaches and reduced prophylactic reliance.

Asia-Pacific presents a mosaic of production systems and regulatory environments that influence both demand and distribution models. High-density poultry production in parts of the region sustains robust demand for accessible, cost-effective anticoccidial programs, while emerging regulatory harmonization efforts are increasing expectations around residue monitoring and quality assurance. Concurrently, digital commerce and evolving veterinary services in parts of Asia-Pacific accelerate adoption of alternative distribution channels. Across regions, localized resistance profiles, feed mill density, and the prevalence of contract farming models combine to determine which product types and forms gain traction, underscoring the need for regionally adapted regulatory strategies and commercial playbooks.

Key company insights emphasizing strategic behaviors, R&D focus areas, and collaborative models shaping competitive dynamics in the anticoccidial space

Market participants exhibit diverse strategic postures that reflect their scale, portfolio breadth, and vertical integration. Large multinational animal health firms prioritize innovation in formulation stability, resistance mitigation technologies, and integrated service offerings that bundle diagnostics and stewardship programs. These organizations invest in global regulatory affairs capabilities to navigate differing residue and registration requirements and often deploy multi-channel distribution models to reach both industrial integrators and smaller independent producers. Mid-sized and regional manufacturers focus on cost-competitive formulations, local regulatory expertise, and supply chain reliability, leveraging proximity to feed mill networks and contract farming clusters.

Across the value chain, contract manufacturing and co-development partnerships have become more common as companies seek to expand capacity without incurring full-scale capital commitments. Collaborative research arrangements between pharmaceutical developers, academic institutions, and diagnostic providers aim to accelerate resistance monitoring tools and refined dosing regimens. Meanwhile, specialized feed additive firms and premix suppliers are differentiating through product customization, technical services, and superior traceability to meet the exacting needs of integrated producers. These company-level behaviors indicate a market where competitive advantage increasingly derives from combined expertise in formulation, regulatory navigation, and on-farm advisory capability rather than solely from molecule ownership.

Actionable recommendations for industry leaders to align product development, commercial strategy, and stewardship with evolving market realities

Industry leaders should prioritize integrated approaches that link product efficacy with on-farm implementation and resistance management. Investing in diagnostics and surveillance partnerships will improve the targeting of therapeutic interventions and support data-driven rotation or combination strategies that preserve efficacy. In parallel, enhancing formulation compatibility with common feed mill workflows and water medication systems will reduce barriers to adoption and improve dosing accuracy. These technical investments should be coupled with educational programs for veterinarians and feed managers to ensure correct use and to reinforce stewardship principles.

On the commercial front, firms should diversify distribution strategies to include strengthened direct-sales capabilities, partnerships with specialty providers, and compliant digital channels that expand reach while maintaining quality assurance. Companies exposed to trade-related cost volatility should evaluate nearshoring options, contractual hedging practices, and supplier diversification to preserve continuity. Finally, leaders must proactively engage regulatory stakeholders and processors on residue monitoring, labeling, and acceptable usage frameworks, because early alignment can de-risk launches and facilitate smoother market access across jurisdictions. Taken together, these measures will help reconcile commercial objectives with the imperative to maintain long-term therapeutic effectiveness.

Research methodology detailing data collection, validation processes, and analytical techniques used to ensure reliability and applicability of findings

The research draws upon a mixed-methods approach combining primary interviews, secondary literature analysis, and supply chain mapping to build a comprehensive evidence base. Primary inputs included structured interviews with veterinarians, feed mill managers, contract manufacturers, and distribution specialists to capture operational realities and adoption barriers. Secondary sources included peer-reviewed literature on coccidiosis biology and treatment efficacy, regulatory filings, product labels, and public trade documentation to corroborate technical and policy contexts.

Data were triangulated to validate trends and reconcile conflicting accounts, with iterative cross-checking between field insights and document-level evidence. Where applicable, regional regulatory databases and customs documentation were consulted to understand tariff impacts and registration constraints. Analytical techniques emphasized qualitative thematic synthesis and comparative regional analysis rather than numerical market sizing, ensuring the report provides actionable strategic intelligence while maintaining methodological transparency. Limitations include variability in reporting standards across jurisdictions and the evolving nature of resistance surveillance data, which the research addresses through conservative interpretation and clear signaling of evidence strength.

Conclusion summarizing the strategic imperatives for stakeholders operating in the anticoccidial domain and the pathways to sustainable therapeutic effectiveness

The anticoccidial landscape is being reshaped by scientific advances, regulatory pressures, shifting distribution models, and trade dynamics. Maintaining therapeutic effectiveness will require integrated strategies that link product innovation with stewardship, robust supply chain design, and targeted commercial engagement. Companies that succeed will be those that align formulation development with on-farm practices, invest in resistance monitoring partnerships, and adopt distribution models that preserve quality while expanding access.

Moving forward, stakeholders should treat resistance management and regulatory alignment as central strategic priorities rather than compliance afterthoughts. By doing so, they will protect efficacy, support animal welfare and food-safety objectives, and create differentiable value propositions for processors and producers. The combined emphasis on diagnostics, formulation compatibility, and adaptive sourcing will define competitiveness in the coming years, enabling sustainable use of anticoccidial interventions across diverse production systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising Eimeria species resistance to traditional ionophore drugs driving development of novel synthetic anticoccidials
  • 5.2. Adoption of precision agriculture monitoring tools to optimize anticoccidial dosing schedules in poultry operations
  • 5.3. Expansion of herbal and phytogenic anticoccidial formulations targeting organic and free range poultry producers
  • 5.4. Strategic partnerships between biotech startups and animal health firms accelerating vaccine based anticoccidial solutions
  • 5.5. Integration of gut microbiome analysis to customize anticoccidial protocols and improve flock health outcomes
  • 5.6. Increased regulatory restrictions on antibiotic growth promoters accelerating shift to vaccination and alternative coccidiosis control
  • 5.7. Development of combination chemistries pairing ionophore and chemical actives to combat multidrug resistant coccidia strains
  • 5.8. Use of machine learning predictive models for early detection and targeted treatment of coccidiosis outbreaks in broiler farms

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Anticoccidial Drugs Market, by End Use

  • 8.1. Cattle
  • 8.2. Poultry
    • 8.2.1. Broiler Chicken
    • 8.2.2. Layer Chicken
  • 8.3. Swine

9. Anticoccidial Drugs Market, by Distribution Channel

  • 9.1. Direct Sales
  • 9.2. Online Pharmacies
  • 9.3. Specialty Stores

10. Anticoccidial Drugs Market, by Product Type

  • 10.1. Ionophores
    • 10.1.1. Lasalocid
    • 10.1.2. Monensin
    • 10.1.3. Salinomycin
  • 10.2. Synthetic Drugs
    • 10.2.1. Nitrofurans
    • 10.2.2. Quinolones
    • 10.2.3. Sulfonamides

11. Anticoccidial Drugs Market, by Form

  • 11.1. Feed Additive
  • 11.2. Liquid
  • 11.3. Premix

12. Anticoccidial Drugs Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Anticoccidial Drugs Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Anticoccidial Drugs Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Zoetis Inc.
    • 15.3.2. Merck & Co., Inc.
    • 15.3.3. Elanco Animal Health Incorporated
    • 15.3.4. Boehringer Ingelheim International GmbH
    • 15.3.5. Bayer Aktiengesellschaft
    • 15.3.6. Ceva Sante Animale
    • 15.3.7. Kemin Industries, Inc.
    • 15.3.8. Huvepharma AD
    • 15.3.9. Novus International, Inc.
    • 15.3.10. DCBL Pharmaceuticals Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. ANTICOCCIDIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. ANTICOCCIDIAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANTICOCCIDIAL DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY BROILER CHICKEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY BROILER CHICKEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY BROILER CHICKEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY BROILER CHICKEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY BROILER CHICKEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY BROILER CHICKEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LAYER CHICKEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LAYER CHICKEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LAYER CHICKEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LAYER CHICKEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LAYER CHICKEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LAYER CHICKEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LASALOCID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LASALOCID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LASALOCID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LASALOCID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LASALOCID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LASALOCID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY MONENSIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY MONENSIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY MONENSIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY MONENSIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY MONENSIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY MONENSIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SALINOMYCIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SALINOMYCIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SALINOMYCIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SALINOMYCIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SALINOMYCIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SALINOMYCIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY NITROFURANS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY NITROFURANS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY NITROFURANS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY NITROFURANS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY NITROFURANS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY NITROFURANS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY QUINOLONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY QUINOLONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY QUINOLONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY QUINOLONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY QUINOLONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY QUINOLONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SULFONAMIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SULFONAMIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SULFONAMIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY SULFONAMIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FEED ADDITIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FEED ADDITIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FEED ADDITIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY FEED ADDITIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PREMIX, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PREMIX, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PREMIX, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PREMIX, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PREMIX, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY PREMIX, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 162. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 178. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 220. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 222. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 226. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 235. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 236. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 237. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 238. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 239. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 242. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 269. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 270. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 271. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 272. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 273. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 276. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 281. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 284. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 285. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 288. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 289. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 292. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 293. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 294. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 295. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 296. GCC ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 313. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 316. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 317. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 318. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 319. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 320. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 321. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 324. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 325. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 326. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 327. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 328. BRICS ANTICOCCIDIAL DRUGS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 329. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 330. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 331. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 332. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 333. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2018-2024 (USD MILLION)
  • TABLE 334. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, 2025-2032 (USD MILLION)
  • TABLE 335. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 336. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 337. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 339. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2018-2024 (USD MILLION)
  • TABLE 340. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORES, 2025-2032 (USD MILLION)
  • TABLE 341. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2018-2024 (USD MILLION)
  • TABLE 342. G7 ANTICOCCIDIAL DRUGS MARKET SIZE, BY SYNTHETIC DRUGS, 2025-2032 (USD MILLION)
  • TABLE 343. G7 ANTI